Table 4.

The Visual Activity Improvement and Incidence of Macular Edema and Neovascular Glaucoma in RVO Cases with or without OSA After Three Months Follow-Up

Subjects	Non-OSA (n=15)	OSA (n=30)	P value
VA improvement over 2 lines	11 (73.3%)	12 (40.0%)	0.036
ME	2 (13.3%)	11 (36.7%)	0.098
NVG	0 (0.0%)	1 (3.3%)	0.669

Notes: Comparison among groups was calculated using unpaired t-test and chi-square exact test; the comparisons with a significant difference were marked in bold.

Abbreviations: OSA, obstructive sleep apnea; VA, visual activity; ME, macular edema; NVG, neovascular glaucoma.